Sundance Strategies (SUND) 10-K 29 Jun 22 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Mar. 31, 2022	Jun. 29, 2022	Sep. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--03-31
Entity File Number	000-50547
Entity Registrant Name	SUNDANCE STRATEGIES, INC.
Entity Central Index Key	0001171838
Entity Tax Identification Number	88-0515333
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	4626 North 300 West
Entity Address, Address Line Two	Suite No. 365
Entity Address, City or Town	Provo
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84604
City Area Code	(801)
Local Phone Number	717-3935
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	SUND
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	true
Entity Shell Company	false
Entity Public Float			$ 103,208,050
Entity Common Stock, Shares Outstanding		41,408,441
Documents Incorporated by Reference [Text Block]	None
Auditor Firm ID	3627
Auditor Name	Sadler, Gibb & Associates, LLC
Auditor Location	Draper, UT

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Current Assets
Cash and cash equivalents	$ 267,966	$ 21,179
Prepaid expenses and other assets	8,167	9,393
Total Current Assets	276,133	30,572
Current Liabilities
Accounts payable	580,972	893,675
Accrued expenses	354,205	215,443
Notes payable	300,000
Current portion of notes payable, related parties	876,000	826,000
Stock repurchase payable	400,000	400,000
Total Current Liabilities	2,511,177	2,335,118
Long-Term Liabilities
Accrued expenses	666,015	495,708
Notes payable, related parties, net of current portion	2,125,808	1,915,808
Total Long-Term Liabilities	2,791,823	2,411,516
Total Liabilities	5,303,000	4,746,634
Stockholders’ Deficit
Preferred stock, authorized 10,000,000 shares, par value $0.001; -0- shares issued and outstanding
Common stock, authorized 500,000,000 shares, par value $0.001; 41,408,441 and 40,108,441 shares issued and outstanding as of March 31, 2022 and 2021, respectively	41,409	40,109
Additional paid in capital	27,181,618	24,728,638
Accumulated deficit	(32,249,894)	(29,484,809)
Total Stockholders’ Deficit	(5,026,867)	(4,716,062)
Total Liabilities and Stockholders’ Deficit	$ 276,133	$ 30,572

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Mar. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	500,000,000	500,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	41,408,441	40,108,441
Common stock, shares outstanding	41,408,441	40,108,441

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Income from Investments
General and Administrative Expenses	690,709	907,978
Loss from Operations	(690,709)	(907,978)
Other Income (Expense)
Gain (loss) on extinguishment of debt	(1,869,971)	26,458
Gain on settlement of liabilities	285,192
Interest expense	(287,687)	(225,296)
Financing expense	(197,761)	(422,751)
Total Other Expense	(2,070,227)	(621,589)
Loss Before Income Taxes	(2,760,936)	(1,529,567)
Income Tax Provision (Benefit)	4,149
Net Loss	$ (2,765,085)	$ (1,529,567)
Loss per share - basic and diluted	$ (0.07)	$ (0.04)
Weighted average shares outstanding - basic and diluted	41,218,263	38,904,715

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Mar. 31, 2020	$ 37,829	$ 24,191,224	$ (27,955,242)	$ (3,726,189)
Beginning balance, shares at Mar. 31, 2020	37,828,441
Common stock issued for consulting services	$ 280	5,964		6,244
Common stock issued for consulting services, shares	280,000
Common stock issued for director compensation	$ 1,500	31,950		33,450
Common stock issued for director compensation, shares	1,500,000
Common stock issued for cash	$ 500	499,500		500,000
Common stock issued for cash, shares	500,000
Net loss			(1,529,567)	(1,529,567)
Ending balance, value at Mar. 31, 2021	$ 40,109	24,728,638	(29,484,809)	(4,716,062)
Ending balance, shares at Mar. 31, 2021	40,108,441
Common stock issued for director compensation	$ 1,200	72,720		73,920
Common stock issued for director compensation, shares	1,200,000
Net loss			(2,765,085)	(2,765,085)
Common stock and warrants issued for cash	$ 100	499,900		500,000
Common stock and warrants issued for cash, shares	100,000
Warrants issued in connection with debt issuances		40,211		40,211
Warrants issued in connection to extinguishment of debt		1,840,149		1,840,149
Ending balance, value at Mar. 31, 2022	$ 41,409	$ 27,181,618	$ (32,249,894)	$ (5,026,867)
Ending balance, shares at Mar. 31, 2022	41,408,441

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating Activities
Net Loss	$ (2,765,085)	$ (1,529,567)
Adjustments to reconcile to net cash used in operating activities:
Share based compensation - common stock	73,920	39,694
Expense paid on behalf of Company by director		7,000
Gain on settlement of liabilities	(285,192)
Loss (gain) on extinguishment of debt	1,869,971	(26,458)
Amortization of debt discount	10,389
Changes in operating assets and liabilities
Prepaid expenses and other assets	1,226	(7,188)
Accounts payable	(27,511)	411,959
Accrued expenses	309,069	286,197
Net Cash used in Operating Activities	(813,213)	(818,363)
Financing Activities
Proceeds from issuance of notes payable, related party	260,000	284,300
Proceeds from issuance of notes payable	300,000
Common stock issued for cash	500,000	500,000
Proceeds from Paycheck Protection Program loan		26,458
Debt issuance costs
Net Cash provided by Financing Activities	1,060,000	810,758
Net Change in Cash and Cash Equivalents	246,787	(7,605)
Cash and Cash Equivalents at Beginning of Period	21,179	28,784
Cash and Cash Equivalents at End of Period	267,966	21,179
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Non Cash Financing & Investing Activities, and Other Disclosures
Issued warrants as debt issuance costs	$ 40,211

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	ORGANIZATION AND BASIS OF PRESENTATION Sundance Strategies, Inc. (formerly known as Java Express, Inc.) was organized under the laws of the State of Nevada on December 14, 2001, and engaged in the retail selling of beverage products to the general public until these endeavors ceased in 2006; it had no material business operations from 2006, until its acquisition of ANEW LIFE, INC. (“ANEW LIFE”), a subsidiary of Sundance Strategies, Inc. (“Sundance Strategies”, “the Company”, “we” or “our”). Our historical business model has focused on purchasing or acquiring life insurance policies and residual interests in or financial products tied to life insurance policies, including notes, drafts, acceptances, open accounts receivable and other obligations representing part or all of the sales price of insurance, life settlements and related insurance contracts being traded in the secondary marketplace, often referred to as the “life settlements market.” During the latter part of the fiscal year ended March 31, 2021, the Company began developing an additional business offering, providing professional services to specialty structured finance groups, bond issuers and life settlement aggregators. The Company has now assembled an experienced team from the life settlement marketplace, as well as from other areas such as financial services and public financial markets. As a professional services provider, the Company applies industry best practices to advise on the selection of specific portfolios of life insurance policies that are tailored to meet the needs of its clients. The Company’s clients may include bond issuers, bond investors, or other structured finance product issuers. The Company develops strategies and methodologies which include the acquisition of life insurance portfolios, then uses common structured finance techniques and proprietary analytics to structure bonds for issuances, including principal protected bonds. The Company’s goal is to deliver long-term value and profitability to shareholders by growing the Company’s professional services business and asset base, resulting in the ability to pay dividends to its shareholders. During the latter part of the year ended March 31, 2021, the Company began working closely with bond placement agents and aggregators to establish various aspects of a proprietary, investment grade bond offering. In this arrangement, the Company participates as the sole originator in the role of structuring and advising on the structure of the proprietary bond instrument. Included in the role of structuring financial assets, the Company uses proprietary analytics to establish the makeup of the rated instrument, including but not limited to, life settlement assets (life insurance policies) and managed cash, and implements a process of selective assembly of the underlying assets and cash management that will meet the policy requirements and analytics. The Company provides current and ongoing resources for all analytics, as well as advisement support for the investment and non-investment grade ratings for the managed asset pool and the managed cash accounts. In its advisory role, the Company is reimbursed for all expenses associated with the structuring and preparation of any bond offering, will receive an advisory payment upon the closing of any bond offering, and then will hold residual rights on the balance of assets once the bond is retired. On January 1, 2022, the Company entered into a marketing and consulting agreement with Tradability, LLC (“Consultant”) that requires the Company to make an initial $ 100,000 400,000 400,000 1,000,000 10,000,000 1.00 2.50 500 100 500 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	(2) SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Estimates Cash and Cash Equivalents Basic and Diluted Net Loss Per Common Share , Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the years ended March 31, 2022 and 2021, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of March 31, 2022 and 2021 include warrants convertible into 7,520,241 and 3,488,754 shares of common stock, respectively. Stock Based Compensation and Financing Costs Income Taxes The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet. Interest and penalties for uncertain positions, when applicable, would be recognized as a component of income tax expense. The Company files United States Federal and State income tax returns. The income tax returns of the Company are subject to examination by taxing authorities for three to five years from the date they are filed. The Company has tax returns subject to examination for 2016-2021. Principles of Consolidation Fair Value SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021 Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the years ended March 31, 2022 and 2021. The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the Notes Payable, Related Parties and Convertible Debenture approximates the fair values as the interest rate approximates market interest rates.

NEW ACCOUNTING PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	12 Months Ended
	Mar. 31, 2022
Accounting Changes and Error Corrections [Abstract]
NEW ACCOUNTING PRONOUNCEMENTS	(3) NEW ACCOUNTING PRONOUNCEMENTS The Company has reviewed all other recently issued, but not yet adopted, accounting standards, in order to determine their effects, if any, on its results of operations, financial position or cash flows. Based on that review, the Company believes that none of these pronouncements will have a significant effect on its financial statements.

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS	12 Months Ended
	Mar. 31, 2022
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS	(4) CASH AND CASH EQUIVALENTS Cash and cash equivalents consist principally of currency on hand and demand deposits at commercial banks. The Company had $ 267,966 21,179 250,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	12 Months Ended
	Mar. 31, 2022
Equity [Abstract]
STOCKHOLDERS’ EQUITY	(5) STOCKHOLDERS’ EQUITY Common Stock On October 29, 2021, the Company issued a private placement memorandum offering to raise up to $ 500,000 0.001 100,000 5 500,000 5 five 500,000 On May 4, 2021, the Company issued 1,200,000 shares of the Company’s common stock to members of the Board of Directors in lieu of cash compensation. The stock awards vested 25 % on the date of grant and the remainder of the shares vested equally over the three months following the date granted. Using a fair value stock price of $ 0.062 per share, the transaction resulted in a compensation expense of $ 73,920 . During August 2020, the Company awarded members of the Board of Directors a total of 1,500,000 25% 100% 0.0223 33,450 On October 5, 2020, the Company granted one of its consultants 280,000 0.0223 6,244 On November 10, 2020, the Company issued a private placement memorandum offering to raise up to $ 1,000,000 0.001 500,000 1 500,000 Effective December 6, 2018, three existing stockholders have contributed to the Company a portion of their common shares held at a repurchase price to the Company of $ 0.05 8,000,000 400,000 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021 Warrants to Purchase Common Stock The following table summarizes the changes in warrants outstanding of the Company during years ended March 31, 2022 and 2021: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Outstanding at March 31, 2020 1,702,000 $ 0.05 Granted 1,786,754 0.05 Outstanding at March 31, 2021 3,488,754 0.05 Granted 3,761,487 0.99 Outstanding at March 31, 2022 7,250,241 $ 0.54 The Company’s related party lenders consist of: the Chairman of the Board of Directors and a stockholder, Radiant Life, LLC and Mr. Dickman, a board member and stockholder. These holders of the related party unsecured promissory notes, hold agreements that provide each related party with common stock warrants upon the lender’s extension of a maturity due date or upon the loaning of additional monies. The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant) 0.05 5 On February 5, 2022, the Company issued 649,754 warrants to Radiant Life, LLC, 653,150 warrants to the Chairman of the Board of Directors and a stockholder and 488,583 warrants to Mr. Dickman in conjunction with various extensions of maturity dates during the period (see Note 7) per the terms outlined above. The exercise price of these warrants was $ 0.05 . The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was $ 1,840,149 . The inputs used in this calculation included a fair value of the underlying common stock of $ 1.049 per share, a risk-free of 1.76 %, volatility of 131.78 % and a dividend rate of 0 %. Subsequent to March 31, 2022, the exercise price was adjusted from $ 0.05 to $ 1.05 , which was the estimated fair market value of the common stock on the grant date (see Note 11). On January 5, 2022, the Company issued 200,000 0.05 The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was $ 205,393 1.049 1.43 131.78 0 40,211 10,389 29,822 0.05 1.05 Between August 1, 2021 and September 16, 2021, the Company issued 200,000 20,000 0.05 The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was not significant. The inputs used in this calculation included a fair value of $ 0.062 0.81 0.84 41.97 42.01 0 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021 As mentioned above, on October 29, 2021, the Company issued a private placement memorandum offering to raise up to $ 500,000 0.001 100,000 5 500,000 5 five On July 29, 2021, the Company borrowed an additional $ 50,000 50,000 2.00 5 The value of the warrants on the date of grant, as calculated by the Black-Scholes-Merton valuation model, was not significant. The inputs used in this calculation included a fair value of the underlying common stock of $ 0.062 0.66 42.14 0 On April 6, 2021, the Company borrowed $ 300,000 unsecured promissory note with Satco International, Ltd. (see Note 6). In conjunction with this note, the Company issued warrants exercisable into 1,000,000 1.00 three 0.062 0.35 50.3 0 On October 1, 2020, the related party, note payable and line of credit agreement with Radiant Life, LLC, was amended to extend the due date from August 31, 2021 to November 30, 2022 or at the immediate time when alternative financing or other proceeds are received. As per the provision in place, and in conjunction with the extension of the due date of the agreement, the Company also agreed to provide the Radiant Life, LLC with warrants for 579,754 0.05 5 0.0223 0.27 27 0 From April 3, 2020 to October 27, 2020, in the Company issued warrants for 527,600 263,800 Chairman of the Board of Directors and a stockholder, and an additional 679,400 0.05 a 5 of $ 0.0223 0.23 0.39 41.6 123.85 0 The following table summarizes the warrants issued and outstanding as of March 31, 2022: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Warrants Warrants Weighted Average Proceeds to Company 0.05 5,700,241 5,700,241 3.68 $ 285,013 1.00 1,000,000 1,000,000 2.02 1,000,000 2.00 50,000 50,000 4.35 100,000 5.00 500,000 500,000 4.82 2,500,000 7,250,241 7,250,241 $ 3,885,013 The shares of common stock issuable upon exercise of the warrants are not registered with the Securities and Exchange Commission and the holders of the warrants do not have registration rights with respect to the warrants or the underlying shares of common stock.

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE	(6) NOTES PAYABLE On April 6, 2021, the Company borrowed $ 300,000 under an unsecured promissory note with Satco International, Ltd. 8 % annually and was due January 6, 2022 . In conjunction with this note, the Company issued warrants for 1,000,000 1.00 3 unsecured promissory note with Satco International, Ltd. was amended to extend the due date from January 6, 2022 to April 6, 2022 , or at the immediate time when alternative financing or other proceeds are received. This extension has no bearing on the warrants that were issued in conjunction with the original promissory note. This note is separate from the 8 % convertible debenture agreement that the Company has in place with Satco International, Ltd. (see note 7). As of March 31, 2022 accrued interest on the note totaled $ 23,605 . SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021

NOTES PAYABLE, RELATED PARTY

NOTES PAYABLE, RELATED PARTY	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
NOTES PAYABLE, RELATED PARTY	(7) NOTES PAYABLE, RELATED PARTY As of March 31, 2022 and 2021, the Company had borrowed $ 3,001,808 2,741,808 767,358 513,665 Related Party Promissory Notes As of both March 31, 2022 and 2021, the Company owed $ 826,000 8 On February 10, 2022, the notes were amended to extend the due date from November 30, 2021 to October 31, 2022, or at the immediate time when alternative financing or other proceeds are received. 488,583 222,810 On July 29, 2021, the Company entered into an unsecured promissory note agreement with Radiant Life, LLC. This agreement was in conjunction with the Company borrowing $ 50,000 8 July 29, 2022 50,000 2.00 5 2,758 Related Party Note Payable and Line of Credit Agreements As of March 31, 2022 1,066,300 1,056,300 On February 7, 2022, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2022 to November 30, 2023, or at the immediate time when alternative financing or other proceeds are received. March 31, 2022 4,600,000 March 31, 2022, 10,000 7.5 March 31, 2022 222,180 10,000 673,150 0.05 5 2,380,150 As of March 31, 2022 and 2021, the Company owed $ 1,059,508 859,508 2,130,000 On February 7, 2022, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2022 to November 30, 2023, or at the immediate time when alternative financing or other proceeds are received. 7.5 200,000 319,610 200,000 1,099,754 5 50,000 2.00 0.05 1,679,508 SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021

CONVERTIBLE DEBENTURE AGREEMENT

CONVERTIBLE DEBENTURE AGREEMENT	12 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
CONVERTIBLE DEBENTURE AGREEMENT	(8) CONVERTIBLE DEBENTURE AGREEMENT The Company has entered into an 8% convertible debenture agreement with Satco International, Ltd., that allows for borrowings of up to $ 3,000,000 Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $ 1.00 June 2, 2016 January 6, 2022 As of March 31, 2022 and March 31, 2021, the Company owed $ 0 124,225

LIQUIDITY REQUIREMENTS

LIQUIDITY REQUIREMENTS	12 Months Ended
	Mar. 31, 2022
Liquidity Requirements
LIQUIDITY REQUIREMENTS	(9) LIQUIDITY REQUIREMENTS Since the Company’s inception on January 31, 2013, its operations have been primarily financed through sales of equity, debt financing from related parties and the issuance of notes payable and convertible debentures. As of March 31, 2022, the Company had $ 267,966 of cash assets, compared to $ 21,179 as of March 31, 2021. As of March 31, 2022, the Company had access to draw an additional $ 4,604,192 on the notes payable, related party (see Note 7) and $ 3,000,000 on the Convertible Debenture Agreement (See Note 7). For the year ended March 31, 2022, the Company’s average monthly operating expenses were approximately $ 75,000 , which includes salaries of our employees, consulting agreements and contract labor, general and administrative expenses and legal and accounting expenses. The Company anticipates the average monthly expenses of $ 75,000 to decrease by approximately $ 10,000 over the next 12 months, resulting in ongoing, average monthly expenses of approximately $ 65,000 . In addition to the monthly operating expenses, the Company continues to pursue other debt and equity financing opportunities, and as a result, financing expenses of $ 197,761 and $ 422,751 were incurred during the years ended March 31, 2022, and 2021, respectively. As management continues to explore additional financing alternatives, beginning April 1, 2022 the Company is expected to spend up to an additional $ 400,000 on these efforts. Outstanding Accounts Payable as of March 31, 2022 totaled $ 580,972 . Management has concluded that its existing capital resources and availability under its existing convertible debentures and debt agreements with related parties will be sufficient to fund its operating working capital requirements for at least the next 12 months, or through June 2022. Related parties have given assurance that their continued support, by way of either extensions of due dates, or increases in lines-of-credit, can be relied on. As mentioned above, the Company also continues to evaluate other debt and equity financing opportunities. The recent outbreak of COVID-19 originated in Wuhan, China, in December 2019 and has since spread to multiple countries, including the United States and several European countries. On March 11, 2020, the World Health Organization declared the outbreak a pandemic. The COVID-19 pandemic is affecting the United States and global economies and may affect the Company’s operations and those of third parties on which the Company relies. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic is difficult to assess or predict, the impact of the COVID-19 pandemic on the global financial markets may reduce the Company’s ability to access capital, which could negatively impact the Company’s short-term and long-term liquidity. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. The Company does not yet know the full extent of potential delays or impacts on its business, financing or other activities or on healthcare systems or the global economy as a whole. However, these effects could have a material impact on the Company’s liquidity, capital resources, operations and business and those of the third parties on which we rely. The accompanying financial statements have been prepared on a going concern basis under which the Company is expected to be able to realize its assets and satisfy its liabilities in the normal course of business. SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021

INCOME TAXES

INCOME TAXES	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	(10) INCOME TAXES The Company provides for income taxes under ASC 740, Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. The Company recorded $ 4,149 0 The income tax provision differs from the amount of income tax determined by applying the U.S. federal tax rate of 21% to pretax income from continuing operations for the years ended March 31, 2022 and 2021, due to the following: SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2022 2021 Income tax benefit at U. S. federal statutory rates: $ (579,797 ) $ (321,209 ) State tax, net of federal benefit (103,817 ) (59,814 ) Change in valuation allowance 215,724 374,407 Other 3,632 - Income Tax $ 4,149 $ - The tax effects of significant items comprising the Company’s net deferred taxes as of March 31, 2022 and 2021 were as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2022 2021 Deferred Tax assets: Net operating loss carry forwards $ 7,164,235 $ 6,948,511 Stock and warrant compensation 479,708 479,708 Valuation allowance (7,643,943 ) (7,428,219 ) Net deferred tax asset $ - $ - The Company assesses the need for a valuation allowance against its deferred income tax assets at March 31, 2022. Factors considered in this assessment include recent and expected future earnings and the Company’s liquidity and equity positions. The Company has placed a 100% valuation allowance on the deferred tax assets. The deferred tax assets primarily relate to net operating loss carryforwards. As of March 31, 2022, the Company has U.S. federal net operating loss carryforwards of $ 28,812,816 expire in 2023 Under FASB ASC 740-10-05-6, tax benefits are recognized only for the tax positions that are more likely than not to be sustained upon examination by tax authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50 percent The Company had no no

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	(11) SUBSEQUENT EVENTS Subsequent to year end, the following events transpired: On June 20, 2022, the Company amended the agreements with the related party lenders to adjust the exercise price of the warrants issued in conjunction with extensions of due dates and new monies lent on the outstanding notes payable, related parties (see Note 5 and Note 7). The original agreements stated that the exercise price of the warrants issued was $ 0.05 0.05 1.05 0.05 1.05 On June 15, 2022 the unsecured promissory note with Satco International, Ltd. (see Note 5) was amended to extend the due date from April 6, 2022 to July 6, 2022

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Estimates	Estimates
Cash and Cash Equivalents	Cash and Cash Equivalents
Basic and Diluted Net Loss Per Common Share	Basic and Diluted Net Loss Per Common Share , Basic net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods presented using the treasury stock method. Diluted net loss per common share is computed by including common shares that may be issued subject to existing rights with dilutive potential, when applicable. Potential dilutive common stock equivalents are primarily comprised of potential dilutive shares resulting from convertible debt agreements and common stock warrants. Potentially dilutive shares resulting from convertible debt agreements are evaluated using the if-converted method. Potentially dilutive securities are not included in the calculation of diluted net loss per share for the years ended March 31, 2022 and 2021, because to do so would be anti-dilutive. Potentially dilutive securities outstanding as of March 31, 2022 and 2021 include warrants convertible into 7,520,241 and 3,488,754 shares of common stock, respectively.
Stock Based Compensation and Financing Costs	Stock Based Compensation and Financing Costs
Income Taxes	Income Taxes The tax effects from an uncertain tax position can be recognized in the financial statements only if the position is more likely than not of being sustained if the position were to be challenged by a taxing authority. The Company has examined the tax positions taken in its tax returns and determined that there are no uncertain tax positions. As a result, the Company has recorded no uncertain tax liabilities in its balance sheet. Interest and penalties for uncertain positions, when applicable, would be recognized as a component of income tax expense. The Company files United States Federal and State income tax returns. The income tax returns of the Company are subject to examination by taxing authorities for three to five years from the date they are filed. The Company has tax returns subject to examination for 2016-2021.
Principles of Consolidation	Principles of Consolidation
Fair Value	Fair Value SUNDANCE STRATEGIES, INC. AND SUBSIDIARY NOTES TO CONSOLIDATED FINANCIAL STATEMENTS March 31, 2022 and 2021 Those levels of input are summarized as follows: ● Level 1: Quoted prices in active markets for identical assets and liabilities. ● Level 2: Observable inputs other than Level 1 quoted prices, such as quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ● Level 3: Unobservable inputs that are supported by little or no market activity. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques as well as instruments for which the determination of fair value requires significant management judgment or estimation. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company did not have any transfers of assets and liabilities between Levels 1, 2 and 3 of the fair value measurement hierarchy during the years ended March 31, 2022 and 2021. The Company’s recorded values of cash and cash equivalents, accounts payable and accrued liabilities approximate their fair values based on their short-term nature. The recorded values of the Notes Payable, Related Parties and Convertible Debenture approximates the fair values as the interest rate approximates market interest rates.

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	12 Months Ended
	Mar. 31, 2022
Equity [Abstract]
SCHEDULE OF WARRANT OUTSTANDING	The following table summarizes the changes in warrants outstanding of the Company during years ended March 31, 2022 and 2021: SCHEDULE OF WARRANT OUTSTANDING Number of Warrants Weighted Average Outstanding at March 31, 2020 1,702,000 $ 0.05 Granted 1,786,754 0.05 Outstanding at March 31, 2021 3,488,754 0.05 Granted 3,761,487 0.99 Outstanding at March 31, 2022 7,250,241 $ 0.54
SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING	The following table summarizes the warrants issued and outstanding as of March 31, 2022: SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING Exercise Warrants Warrants Weighted Average Proceeds to Company 0.05 5,700,241 5,700,241 3.68 $ 285,013 1.00 1,000,000 1,000,000 2.02 1,000,000 2.00 50,000 50,000 4.35 100,000 5.00 500,000 500,000 4.82 2,500,000 7,250,241 7,250,241 $ 3,885,013

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)	SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) 2022 2021 Income tax benefit at U. S. federal statutory rates: $ (579,797 ) $ (321,209 ) State tax, net of federal benefit (103,817 ) (59,814 ) Change in valuation allowance 215,724 374,407 Other 3,632 - Income Tax $ 4,149 $ -
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES	The tax effects of significant items comprising the Company’s net deferred taxes as of March 31, 2022 and 2021 were as follows: SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES 2022 2021 Deferred Tax assets: Net operating loss carry forwards $ 7,164,235 $ 6,948,511 Stock and warrant compensation 479,708 479,708 Valuation allowance (7,643,943 ) (7,428,219 ) Net deferred tax asset $ - $ -

ORGANIZATION AND BASIS OF PRE_2

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - Consulting Agreement [Member] $ / shares in Units, Integer in Millions	Jan. 02, 2022 USD ($) Integer $ / shares shares
Property, Plant and Equipment [Line Items]
Payments to acquire loans held-for-investment	$ 100,000
Proceeds from issuance of upon contingent milestones	400,000
Maximum [Member]
Property, Plant and Equipment [Line Items]
Repayment of related party debt	$ 400,000
Stock option granted | shares	10,000,000
Share based compensation exercise price per share | $ / shares	$ 2.50
Proceeds from non fungible token	$ 500,000,000
Minimum [Member]
Property, Plant and Equipment [Line Items]
Stock option granted | shares	1,000,000
Share based compensation exercise price per share | $ / shares	$ 1
Number of milestone non fungible | Integer	500
Proceeds from non fungible token	$ 100,000,000

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accounting Policies [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	7,520,241	3,488,754

CASH AND CASH EQUIVALENTS (Deta

CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 267,966	$ 21,179
FDIC insured amount	$ 250,000

SCHEDULE OF WARRANT OUTSTANDING

SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of Warrants Outstanding, Ending Balance	7,250,241
Warrant [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of Warrants Outstanding, Beginning Balance	3,488,754	1,702,000
Weighted Average Exercise Price, Beginning Balance	$ 0.05	$ 0.05
Number of Warrants, Granted	3,761,487	1,786,754
Weighted Average Exercise Price, Granted	$ 0.99	$ 0.05
Number of Warrants Outstanding, Ending Balance	7,250,241	3,488,754
Weighted Average Exercise Price, Ending Balance	$ 0.54	$ 0.05

SCHEDULE OF WARRANTS ISSUED AND

SCHEDULE OF WARRANTS ISSUED AND OUTSTANDING (Details)	12 Months Ended
	Mar. 31, 2022 USD ($) $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Outstanding	7,250,241
Warrants Exercisable	7,250,241
Proceeds from Warrant Exercised | $	$ 3,885,013
Exercise Price One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price | $ / shares	$ 0.05
Warrant Outstanding	5,700,241
Warrants Exercisable	5,700,241
Weighted Average Remaining Contractual Life (Years)	3 years 8 months 4 days
Proceeds from Warrant Exercised | $	$ 285,013
Exercise Price Two [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price | $ / shares	$ 1
Warrant Outstanding	1,000,000
Warrants Exercisable	1,000,000
Weighted Average Remaining Contractual Life (Years)	2 years 7 days
Proceeds from Warrant Exercised | $	$ 1,000,000
Exercise Price Three [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price | $ / shares	$ 2
Warrant Outstanding	50,000
Warrants Exercisable	50,000
Weighted Average Remaining Contractual Life (Years)	4 years 4 months 6 days
Proceeds from Warrant Exercised | $	$ 100,000
Exercise Price Four [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Warrant Exercise Price | $ / shares	$ 5
Warrant Outstanding	500,000
Warrants Exercisable	500,000
Weighted Average Remaining Contractual Life (Years)	4 years 9 months 25 days
Proceeds from Warrant Exercised | $	$ 2,500,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)

1 Months Ended

2 Months Ended

5 Months Ended

7 Months Ended

9 Months Ended

12 Months Ended

Jan. 05, 2022

Oct. 29, 2021

Jul. 29, 2021

May 04, 2021

Nov. 10, 2020

Oct. 05, 2020

Oct. 01, 2020

Dec. 06, 2018

Aug. 31, 2020

Sep. 16, 2021

Mar. 28, 2022

Oct. 27, 2020

Dec. 31, 2021

Mar. 31, 2022

Mar. 31, 2021

Jun. 24, 2022

Jun. 20, 2022

Feb. 07, 2022

Feb. 05, 2022

Apr. 06, 2021

Accumulated Other Comprehensive Income (Loss) [Line Items]

Common stock, par value

$ 0.001

$ 0.001

Proceeds from issuance of common stock

$ 500,000

$ 500,000

Share Price

$ 1.049

Share-Based Payment Arrangement, Noncash Expense

$ 73,920

39,694

Fair value assumptions, risk free interest rate

1.43%

Fair value assumptions, volatility rate

131.78%

Fair value assumptions, dividend rate

0%

Debt issuance costs

$ 40,211

Amortization of debt discount

10,389

$ 10,389

Debt Instrument, Unamortized Discount

$ 29,822

Stock issued during period, value

$ 500,000

Unsecured Promissory Note [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants exercisable

1,000,000

Warrant exercise price per share

$ 1

Warrant term

3 years

Issuance of warrants

1,000,000

Notes Payable

$ 50,000

$ 300,000

Warrant exercisable price per share

$ 1

Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.05

Valuation Technique, Option Pricing Model [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants and Rights Outstanding

$ 205,393

Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Issuance of warrants

50,000

Radiant Life LLC [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.05

$ 2

$ 0.05

Warrant term

5 years

5 years

Share Price

$ 0.0223

Issuance of warrants

200,000

50,000

579,754

Fair value assumptions, risk free interest rate

0.27%

Fair value assumptions, volatility rate

27%

Fair value assumptions, dividend rate

0%

Radiant Life LLC [Member] | Maximum [Member] | Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 1.05

Radiant Life LLC [Member] | Minimum [Member] | Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

0.05

Radiant Life LLC [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Issuance of warrants

200,000

1,099,754

649,754

Radian Life LLC [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 2

$ 0.05

Warrant term

5 years

5 years

Share Price

$ 0.062

Issuance of warrants

50,000

Fair value assumptions, risk free interest rate

0.66%

Fair value assumptions, volatility rate

42.14%

Fair value assumptions, dividend rate

0%

Due from Related Parties

$ 50,000

Director [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture

1,200,000

1,500,000

Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage

25%

25%

100%

Share Price

$ 0.062

$ 0.0223

Share-Based Payment Arrangement, Noncash Expense

$ 73,920

$ 33,450

Consultants [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture

280,000

Share Price

$ 0.0223

Consulting expense

$ 6,244

Three Existing Shareholders [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Stock repurchase, price per share

$ 0.05

Number of shares cancelled/retired

8,000,000

Number of stock value repurchased

$ 400,000

Board of Directors [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Issuance of warrants

653,150

Board of Directors [Member] | Radiant Life LLC [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.05

Issuance of warrants

20,000

Mr. Dickman [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.05

Share Price

$ 0.062

$ 1.049

Fair value assumptions, dividend rate

0%

0%

Mr. Dickman [Member] | Maximum [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Fair value assumptions, risk free interest rate

0.84%

1.76%

Fair value assumptions, volatility rate

42.01%

131.78%

Mr. Dickman [Member] | Maximum [Member] | Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

1.05

Mr. Dickman [Member] | Minimum [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Fair value assumptions, risk free interest rate

0.81%

Fair value assumptions, volatility rate

41.97%

Mr. Dickman [Member] | Minimum [Member] | Subsequent Event [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant exercise price per share

$ 0.05

Mr. Dickman [Member] | Valuation Technique, Option Pricing Model [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrants and Rights Outstanding

$ 1,840,149

Mr. Dickman [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Issuance of warrants

488,583

Mr. Dickman [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Share Price

$ 0.062

Fair value assumptions, risk free interest rate

0.35%

Fair value assumptions, volatility rate

50.30%

Fair value assumptions, dividend rate

0%

Board of Directors Chairman [Member] | Warrant [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

527,600

Warrant exercise price per share

$ 0.05

Warrant term

5 years

Share Price

$ 0.0223

Fair value assumptions, dividend rate

0%

Stock issued during period, value

$ 263,800

Number of addtional shares isssued

679,400

Fair value assumptions, risk free interest rate, minimum

0.23%

Fair value assumptions, risk free interest rate, maximum

0.39%

Fair value assumptions, volatility rate, minimum

41.60%

Fair value assumptions, volatility rate, maximum

123.85%

Subscription Agreements [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

100,000

500,000

Purchase price per shares

$ 5

$ 1

Warrants exercisable

500,000

Warrant exercise price per share

$ 5

Warrant term

5 years

Proceeds from issuance of common stock

$ 500,000

$ 500,000

Subscription Agreements [Member] | Investor [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Number of shares issued

100,000

Purchase price per shares

$ 5

Warrants exercisable

500,000

Warrant exercise price per share

$ 5

Warrant term

5 years

Notes Payable and Lines of Credit Agree [Member] | Radiant Life LLC [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Warrant or right, reason for issuance, description

The number of warrants issued for an extension is based on the following formula: 10,000 warrants per month the due date is extended plus 1 warrant for every $2 of the principal balance outstanding (not including interest) at the time of the extension (rounded to the nearest whole warrant)

Restricted Stock [Member] | Private Placement Offering [Member]

Accumulated Other Comprehensive Income (Loss) [Line Items]

Issuance of restricted shares

$ 500,000

$ 1,000,000

Common stock, par value

$ 0.001

$ 0.001

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative) - USD ($)			6 Months Ended	12 Months Ended
	Jul. 29, 2021	Apr. 06, 2021	Jun. 24, 2022	Mar. 31, 2022	Jun. 20, 2022
Short-Term Debt [Line Items]
Debt Instrument, Interest Rate, Stated Percentage		8%
Interest Payable				$ 222,810
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member]
Short-Term Debt [Line Items]
Debt Instrument, Maturity Date				Jun. 02, 2016
Subsequent Event [Member]
Short-Term Debt [Line Items]
Warrant exercisable price per share					$ 0.05
Subsequent Event [Member] | 8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member]
Short-Term Debt [Line Items]
Debt Instrument, Maturity Date, Description			January 6, 2022 to April 6, 2022
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Notes Payable	$ 50,000	$ 300,000
Debt Instrument, Interest Rate, Stated Percentage	8%	8%
Debt Instrument, Maturity Date	Jul. 29, 2022	Jan. 06, 2022
Issuance of warrants		1,000,000
Warrant exercisable price per share		$ 1
Warrants expiration term		3 years
Interest Payable				$ 23,605

NOTES PAYABLE, RELATED PARTY (D

NOTES PAYABLE, RELATED PARTY (Details Narrative) - USD ($)				12 Months Ended
	Feb. 10, 2022	Jul. 29, 2021	Apr. 06, 2021	Mar. 31, 2022	Feb. 05, 2022	Jan. 05, 2022	Sep. 16, 2021	Mar. 31, 2021	Oct. 01, 2020
Short-Term Debt [Line Items]
Notes payable, related parties				$ 3,001,808				$ 2,741,808
Accrued interest				124,225				124,225
Debt instrument interest rate			8%
Accrued interest				$ 222,810
Warrant [Member]
Short-Term Debt [Line Items]
Issuance of warrants				50,000
Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Notes payable, related parties				$ 1,066,300				1,056,300
Warrant exercise price per share				$ 2
Warrant term				5 years
Stock repurchase, price per share				$ 0.05
Notes Payable and Lines of Credit Agreement [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Notes payable				$ 4,600,000
Notes Payable and Lines of Credit Agreement [Member] | Extended Maturity [Member]
Short-Term Debt [Line Items]
Maturity date description				On February 7, 2022, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2022 to November 30, 2023, or at the immediate time when alternative financing or other proceeds are received.
Line of Credit Agreement [Member]
Short-Term Debt [Line Items]
Issuance of warrants				2,380,150
Warrant exercise price per share				$ 0.05
Repayments of related party debt				$ 10,000
Line of Credit [Member]
Short-Term Debt [Line Items]
Notes payable				$ 10,000
Radiant Life LLC [Member]
Short-Term Debt [Line Items]
Issuance of warrants		50,000				200,000			579,754
Warrant exercise price per share		$ 2				$ 0.05			$ 0.05
Warrant term		5 years							5 years
Radiant Life LLC [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Issuance of warrants				1,099,754	649,754		200,000
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Notes payable, related parties				$ 1,059,508				859,508
Debt instrument interest rate				7.50%
Notes payable				$ 200,000
Amount borrowed				$ 200,000
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member] | The Company's NIBS [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate				7.50%
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Notes payable				$ 2,130,000
Radiant Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member] | Extended Maturity [Member]
Short-Term Debt [Line Items]
Maturity date description				On February 7, 2022, the related party note payable and line of credit agreement was amended to extend the due date from November 30, 2022 to November 30, 2023, or at the immediate time when alternative financing or other proceeds are received.
Radian Life LLC [Member]
Short-Term Debt [Line Items]
Issuance of warrants		50,000
Warrant exercise price per share		$ 2		$ 0.05
Warrant term		5 years		5 years
Radian Life LLC [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Accrued interest				$ 222,180
The Company's NIBS [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Accrued interest				$ 319,610
Warrant term				5 years
Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Debt instrument interest rate		8%	8%
Accrued interest				$ 23,605
Notes payable		$ 50,000	$ 300,000
Debt maturity date		Jul. 29, 2022	Jan. 06, 2022
Issuance of warrants			1,000,000
Warrant exercise price per share			$ 1
Warrant term			3 years
Unsecured Note Payable [Member]
Short-Term Debt [Line Items]
Interest received				2,758
Related Party [Member]
Short-Term Debt [Line Items]
Accrued interest				767,358				513,665
Mr. Glenn S. Dickman [Member] | Unsecured Promissory Note [Member]
Short-Term Debt [Line Items]
Notes payable, related parties				$ 826,000				$ 826,000
Debt instrument interest rate				8%
Maturity date description	On February 10, 2022, the notes were amended to extend the due date from November 30, 2021 to October 31, 2022, or at the immediate time when alternative financing or other proceeds are received.
Common stock warrant				488,583
Related Party Lender [Member] | Notes Payable and Lines of Credit Agreement [Member]
Short-Term Debt [Line Items]
Issuance of warrants				673,150
Lender [Member]
Short-Term Debt [Line Items]
Issuance of warrants				1,679,508

CONVERTIBLE DEBENTURE AGREEME_2

CONVERTIBLE DEBENTURE AGREEMENT (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Debt Instrument [Line Items]
Amount payable	$ 0	$ 0
Accrued interest	$ 124,225	$ 124,225
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member]
Debt Instrument [Line Items]
Description of convertible terms of conversion	Per the agreement, the number of shares issuable at conversion shall be determined by the quotient obtained by dividing the outstanding principal and accrued and unpaid interest by 90% of the 90-day average closing price of the Company’s common stock from the date the notice of conversion is received; and the price at which the Debenture may be converted will be no lower than $1.00 per share.
Debt convertible conversion price per share	$ 1
Debt maturity date	Jun. 02, 2016
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member] | Extended Maturity [Member]
Debt Instrument [Line Items]
Debt maturity date	Jan. 06, 2022
8% Convertible Debenture Agreement [Member] | Satco International, Ltd., [Member] | Maximum [Member]
Debt Instrument [Line Items]
Debt borrowing amount	$ 3,000,000

LIQUIDITY REQUIREMENTS (Details

LIQUIDITY REQUIREMENTS (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Cash		$ 267,966	$ 21,179
Additional borrowing capacity from related party notes payable		4,604,192
Additional borrowing capacity from convertible debenture		3,000,000
Operating Expenses		75,000
Financing Interest Expense		197,761	$ 422,751
Additional financing alternatives		400,000
Accounts Payable		$ 580,972
Forecast [Member]
Operating Expenses	$ 65,000
Estimated operating expenses	75,000
Increase decrease in operating expense	$ 10,000

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income tax benefit at U. S. federal statutory rates:	$ (579,797)	$ (321,209)
State tax, net of federal benefit	(103,817)	(59,814)
Change in valuation allowance	215,724	374,407
Other	3,632
Income Tax	$ 4,149

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 7,164,235	$ 6,948,511
Stock and warrant compensation	479,708	479,708
Valuation allowance	(7,643,943)	(7,428,219)
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 4,149
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		21%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	100%
Operating loss carryforwards	$ 28,812,816
Operating loss carryforwards expiration date, description	expire in 2023
Income tax examination, likelihood of unfavorable settlement	greater than 50 percent
Unrecognized tax benefits	$ 0
Unrecognized tax benefits interest and penalties	$ 0

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - $ / shares	Jun. 20, 2022	Jun. 15, 2022
Subsequent Event [Line Items]
Warrant Exercise Price	$ 0.05
Increase in warrants exercise price	1.05
Satco International, Ltd., [Member] | Unsecured Debt [Member]
Subsequent Event [Line Items]
Maturity date description		April 6, 2022 to July 6, 2022
Lenders [Member]
Subsequent Event [Line Items]
Warrant Exercise Price	0.05
Lenders [Member] | Minimum [Member]
Subsequent Event [Line Items]
Warrant Exercise Price	0.05
Lenders [Member] | Maximum [Member]
Subsequent Event [Line Items]
Increase in warrants exercise price	$ 1.05